Reproducibility of response to nasal lysine-aspirin challenge in patients with aspirin-induced asthma
- PMID: 15328680
- DOI: 10.1016/S1081-1206(10)61473-1
Reproducibility of response to nasal lysine-aspirin challenge in patients with aspirin-induced asthma
Abstract
Background: Peak nasal inspiratory flow (PNIF) and acoustic rhinometry objectively measure the effects of nasal provocation testing. Although the latter is conventionally used in nasal lysine-aspirin challenge, use of the former in aspirin-induced asthma (AIA) has never been evaluated.
Objective: To evaluate the reproducibility of PNIF and acoustic rhinometry following nasal lysine-aspirin challenge in AIA.
Methods: Fourteen patients with a clear-cut history of AIA underwent nasal lysine-aspirin challenge at 2 separate visits 1 week apart. Both PNIF and minimum cross-sectional area (MCA) were measured using acoustic rhinometry for 120 minutes following standard nasal lysine-aspirin challenge (25 mg).
Results: Prechallenge values were not significantly different at visit 1 vs visit 2 for mean [SEM] PNIF (128 [13] vs 127 [9] L/min) and MCA (6.89 [0.51] vs 6.94 [0.57] cm2). The mean (SEM) maximum percent PNIF change from baseline for visit 1 and visit 2 was -42 (5) and -42 (6), respectively, and the mean (SEM) average percent PNIF change from baseline was -25 (4) and -25 (6), respectively. The mean (SEM) maximum percent MCA change from baseline for visit 1 and visit 2 was -49 (4) and -48 (3), respectively, and the mean (SEM) average percent MCA change from baseline was -25 (8) and -24 (4), respectively. Coefficients of variation for maximum and average responses were 2.3% and 6.5%, respectively, for PNIF and 7.4% and 16.1% for MCA.
Conclusions: Measurement of PNIF following nasal lysine-aspirin challenge is a simple and reproducible alternative to acoustic rhinometry, with maximum response being a more reproducible outcome measure than average response.
Similar articles
-
Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma.Eur Respir J. 2004 Aug;24(2):226-30. doi: 10.1183/09031936.04.00100303. Eur Respir J. 2004. PMID: 15332389 Clinical Trial.
-
An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma.Clin Exp Allergy. 2001 Sep;31(9):1385-91. doi: 10.1046/j.1365-2222.2001.01160.x. Clin Exp Allergy. 2001. PMID: 11591188
-
Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma.J Laryngol Otol. 2007 Dec;121(12):1156-60. doi: 10.1017/S0022215107000515. Epub 2007 Aug 15. J Laryngol Otol. 2007. PMID: 17697437 Clinical Trial.
-
Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.Acta Otorhinolaryngol Belg. 1995;49(3):235-50. Acta Otorhinolaryngol Belg. 1995. PMID: 7484142 Review.
-
[Asthma with hypersensitivity to aspirin].Pol Merkur Lekarski. 2003 Jun;14(84):561-5. Pol Merkur Lekarski. 2003. PMID: 14524272 Review. Polish.
Cited by
-
Hypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis.Curr Allergy Asthma Rep. 2015 Aug;15(8):47. doi: 10.1007/s11882-015-0552-y. Curr Allergy Asthma Rep. 2015. PMID: 26149590 Free PMC article. Review.
-
Asthma and Rhinitis Induced by Selective Immediate Reactions to Paracetamol and Non-steroidal Anti-inflammatory Drugs in Aspirin Tolerant Subjects.Front Pharmacol. 2016 Jul 20;7:215. doi: 10.3389/fphar.2016.00215. eCollection 2016. Front Pharmacol. 2016. PMID: 27489545 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical